CEN BIOTECH, INC.: 10-Q filed 2017-08-21

Name: CEN BIOTECH, INC.: 10-Q filed 2017-08-21
Creator: CEN BIOTECH, INC.

What CEN BIOTECH, INC. reported in its quarterly report filed 2017-08-21 (fiscal Q2 2017): 19 published measures, 50 facts as tagged in accession 0001437749-17-015121.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-08-21
Fiscal period: fiscal Q2 2017
Accession: 0001437749-17-015121 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CEN BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-06-30	4,506,316	USD
At 2016-12-31	4,094,019	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-06-30	20,264,331	USD
At 2016-12-31	17,473,709	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-06-30	-15,758,015	USD
At 2016-12-31	-13,379,690	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-06-30	171,636	USD
At 2016-12-31	62,381	USD
At 2016-06-30	18,727	USD
At 2015-12-31	3,016	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-1,141,417	USD	91
2017-01-01 to 2017-06-30	-2,378,325	USD	181
2016-04-01 to 2016-06-30	-626,362	USD	91
2016-01-01 to 2016-06-30	-1,204,020	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-06-30	-15,768,110	USD
At 2016-12-31	-13,389,785	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-06-30	15,459	USD
At 2016-12-31	16,342	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-553,562	USD	91
2017-01-01 to 2017-06-30	-1,220,114	USD	181
2016-04-01 to 2016-06-30	-237,979	USD	91
2016-01-01 to 2016-06-30	-434,871	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-06-30	171,636	USD
At 2016-12-31	62,381	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-06-30	16,013,132	USD
At 2016-12-31	14,693,985	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-06-30	92,768	USD
At 2016-12-31	157,054	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	553,562	USD	91
2017-01-01 to 2017-06-30	1,220,114	USD	181
2016-04-01 to 2016-06-30	237,979	USD	91
2016-01-01 to 2016-06-30	434,871	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-06-30	10,525,000	shares
At 2016-12-31	10,525,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-06-30	10,000	USD
At 2016-12-31	10,000	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2017-06-30	2,246,052	USD
At 2016-12-31	2,319,852	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-06-30	287,650	USD
At 2016-12-31	840,584	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	310,283	USD	91
2017-01-01 to 2017-06-30	873,645	USD	181
2016-04-01 to 2016-06-30	145,617	USD	91
2016-01-01 to 2016-06-30	284,028	USD	182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	74,684	USD	181
2016-01-01 to 2016-06-30	442	USD	182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-587,855	USD	91
2017-01-01 to 2017-06-30	-1,158,211	USD	181
2016-04-01 to 2016-06-30	-388,383	USD	91
2016-01-01 to 2016-06-30	-769,149	USD	182

Inspect the source

Entity: CEN BIOTECH, INC. / CIK 0001653821
Captured: 2026-09-22 19:54 UTC
SEC response SHA-256: 097c84c6c785c728d94a8aab95d5185c6c0595b9a921b7610327e115a19292be

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001653821.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))